Page last updated: 2024-12-05

pyridoxic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pyridoxic acid is a metabolite of vitamin B6 (pyridoxine). It is formed in the body by the oxidation of pyridoxal 5'-phosphate, the active form of vitamin B6. Pyridoxic acid is not biologically active, but it can be used as a marker of vitamin B6 status. The synthesis of pyridoxic acid typically involves the oxidation of pyridoxine or pyridoxal using chemical reagents such as potassium permanganate or chromic acid. Studies on pyridoxic acid are important for understanding the metabolism of vitamin B6 and for assessing vitamin B6 status in individuals. Pyridoxic acid levels in urine are commonly measured to assess vitamin B6 status, as it is a stable and readily excreted metabolite. Research on pyridoxic acid is ongoing to investigate its potential role in various physiological processes, including brain function, immune response, and cardiovascular health.'

Pyridoxic Acid: The catabolic product of most of VITAMIN B 6; (PYRIDOXINE; PYRIDOXAL; and PYRIDOXAMINE) which is excreted in the urine. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-pyridoxic acid : A methylpyridine that is 2-methylpyridine substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5. It is the catabolic product of vitamin B6 and is excreted in the urine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

4-pyridoxate : A pyridoxate that is the conjugate base of 4-pyridoxic acid, obtained by deprotonation of the carboxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6723
SCHEMBL ID195230
MeSH IDM0018246

Synonyms (46)

Synonym
3-hydroxy-2-methyl-5-methylol-isonicotinic acid
3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinate
3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid
pyridoxic acid
nsc-41814
3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinic acid
3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylic acid
4-pyridoxylic acid
2-methyl-3-hydroxy-4-carboxy-5-hydroxymethylpyridine
isonicotinic acid, 3-hydroxy-5-(hydroxymethyl)-2-methyl-
4-pyridoxinic acid
4-pyridoxinecarboxylic acid
4-pyridinecarboxylic acid, 3-hydroxy-5-(hydroxymethyl)-2-methyl-
nsc 41814
4-pyridoxate
82-82-6
4-pyridoxic acid
4-pyridoxic acid, >=98%
F883B77C-B8C5-4061-8516-221CA6F8ACAC
3-hydroxy-5-hydroxymethyl-2-methyl-isonicotinsaeure
4-pyridoxinecarboxylate
3-hydroxy-5-hydroxymethyl-2-methyl-isonicotinic acid
4-pyridoxylate
3-hydroxy-5-(hydroxymethyl)-2-methyl-isonicotinate
4-pyridoxinate
3-hydroxy-5-hydroxymethyl-2-methyl-isonicotinate
3-hydroxy-5-(hydroxymethyl)-2-methyl-isonicotinic acid
BMSE000930
3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxylate
4-pyridoxinsaeure
unii-5k18793o8d
5k18793o8d ,
FT-0631377
4-pyridoxic acid [mi]
pyridoxic acid, 4-
SCHEMBL195230
HXACOUQIXZGNBF-UHFFFAOYSA-N
AKOS030530767
HY-113493
CS-0062390
DTXSID20861650
Q27102382
LCZC2536
D97439
AS-77155
mfcd00006334

Research Excerpts

Effects

ExcerptReferenceRelevance
"4-pyridoxic acid (PDA) has been identified as the most sensitive plasma endogenous biomarker of renal organic anion transporters (OAT1/3)."( Development of 4-Pyridoxic Acid PBPK Model to Support Biomarker-Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease.
Galetin, A; Rostami-Hodjegan, A; Scotcher, D; Shen, H; Snoeys, J; Tan, SPF; Willemin, ME, 2023
)
1.81

Pharmacokinetics

ExcerptReferenceRelevance
" Plasma clearance and volume of distribution of PLP decreased significantly after supplementation, but half-life t 1/2 did not change."( Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans.
Aronoff, GR; Li, TK; Lui, A; Lumeng, L, 1985
)
0.27
" The objective of this study was to develop a population pharmacokinetic model for PDA and HVA to support biomarker qualification."( Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters.
Ahmad, A; Galetin, A; Jacobs, F; Kunze, A; Ogungbenro, K; Rostami-Hodjegan, A; Snoeys, J, 2021
)
0.85

Bioavailability

ExcerptReferenceRelevance
" These data suggest that dietary fiber, as cellulose or the indigestible component of wheat bran, does not adversely affect the bioavailability of vitamin B-6."( Bioavailability of vitamin B-6 from rat diets containing wheat bran or cellulose.
Betschart, AA; Hudson, CA; Oace, SM, 1988
)
0.27
"The effect of cooked wheat bran on the bioavailability of vitamin B-6 (B-6) was determined in 10 men, aged 20 to 35 years."( The effect of wheat bran on the bioavailability of vitamin B-6 in young men.
Leklem, JE; Lindberg, AS; Miller, LT, 1983
)
0.27
"Relative bioavailability of vitamin B-6 from tuna, whole wheat bread and peanut butter was investigated in eight men."( Comparative vitamin B-6 bioavailability from tuna, whole wheat bread and peanut butter in humans.
Kabir, H; Leklem, JE; Miller, LT, 1983
)
0.27
" The effect of food on the gastric emptying rate of a solution appears to be almost uniform, whereas that for a tablet is so unpredictable that a reliable absorption rate for an enteric-coated tablet cannot be expected, particularly under pre- and post-meal conditions."( Variability in absorption lag time of pyridoxal phosphate under fasting and pre- and post-meal conditions.
Nagai, N; Ogata, H; Shimamura, H; Sugito, K; Takahashi, H, 1994
)
0.29
" For direct assessment of how the bioavailability of vitamin B-6 is affected by aging, [2H]pyridoxine was orally administered to healthy men, aged 20-30 and 60-70 y, who were fed a controlled diet."( Bioavailability of vitamin B-6 in young and older men.
Ferroli, CE; Trumbo, PR, 1994
)
0.29
"Previous research has shown that the pyridoxine glucoside (PNG) form of vitamin B-6 has a reduced bioavailability compared with pyridoxine, but its effect on vitamin B-6 status has not been assessed."( Vitamin B-6 status indicators decrease in women consuming a diet high in pyridoxine glucoside.
Hansen, CM; Leklem, JE; Miller, LT, 1996
)
0.29
" On the contrary, PN-beta-Glc poorly served as vitamin B6 source, because average bioavailability was only about 22% in comparison to that of PN (100%)."( Feeding experiments of pyridoxine derivatives as vitamin B6.
Hayakawa, T; Maeno, M; Morimoto, Y; Suzuki, Y; Tsuge, H, 1997
)
0.3

Dosage Studied

ExcerptRelevanceReference
" The dose-response relation between CRP and B-6 vitamers at day 28 was nonlinear, with an increased steepness of slope at CRP >7 mg/L."( Association of plasma B-6 vitamers with systemic markers of inflammation before and after pyridoxine treatment in patients with stable angina pectoris.
Midttun, Ø; Nygård, O; Pedersen, ER; Ueland, PM; Ulvik, A, 2012
)
0.38
" Study participants with elevated PAr experienced a higher risk of incident stroke in an essentially linear dose-response fashion."( The PAr index, an indicator reflecting altered vitamin B-6 homeostasis, is associated with long-term risk of stroke in the general population: the Hordaland Health Study (HUSK).
Meyer, K; Midttun, Ø; Nygård, O; Tell, GS; Ueland, PM; Ulvik, A; Vollset, SE; Zuo, H, 2018
)
0.48
"PAr was positively associated with lung cancer risk in a dose-response fashion."( Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3).
Albanes, D; Blot, WJ; Brennan, P; Buring, JE; Cai, Q; Caporaso, NE; Ericson, U; Fanidi, A; Freedman, ND; Gao, Y; Gaziano, JM; Giles, GG; Grankvist, K; Han, J; Hodge, A; Hultdin, J; Hveem, K; Johansson, M; Jones, MR; Koh, W; Langhammer, A; Lee, I; Marchand, LL; McCullough, ML; Midttun, Ø; Næss, M; Pettinger, M; Prentice, R; Relton, C; Severi, G; Shu, X; Stampfer, MJ; Stevens, VL; Tell, GS; Thomson, CA; Ueland, PM; Ulvik, A; Visvanathan, K; Wang, R; Weinstein, SJ; Wu, J; Xiang, Y; Yuan, J; Zeleniuch-Jacquotte, A; Zhang, X; Zheng, W; Ziegler, RG; Zuo, H, 2019
)
0.51
" Renal and biliary excretions and plasma concentration-time profiles of KYNA, pyridoxic acid (PDA), homovanillic acid (HVA), and coproporphyrin I (CP-I) were assessed in BDC monkeys dosed with either probenecid (PROB) at 100 mg/kg or the control vehicle."( Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys.
Hao, J; Lai, Y; Liu, R; Zhao, X, 2023
)
1.14
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
human urinary metaboliteAny metabolite (endogenous or exogenous) found in human urine samples.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
vitamin B6Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
methylpyridinesAny member of the class of pyridines that carries at least one methyl substituent.
hydroxymethylpyridineAny member of the class of pyridines carrying a hydroxymethyl substituent at unspecified position.
monohydroxypyridineA hydroxypyridine carrying a single hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (7)

PathwayProteinsCompounds
Metabolism14961108
Metabolism of vitamins and cofactors146155
Metabolism of water-soluble vitamins and cofactors102114
Vitamin B6 activation to pyridoxal phosphate318
Vitamin B6 Metabolism515
Hypophosphatasia515
Vitamin B6 metabolism ( Vitamin B6 metabolism )417

Research

Studies (210)

TimeframeStudies, This Drug (%)All Drugs %
pre-199088 (41.90)18.7374
1990's45 (21.43)18.2507
2000's32 (15.24)29.6817
2010's36 (17.14)24.3611
2020's9 (4.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.42 (24.57)
Research Supply Index5.55 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index46.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials21 (8.94%)5.53%
Reviews8 (3.40%)6.00%
Case Studies1 (0.43%)4.05%
Observational0 (0.00%)0.25%
Other205 (87.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]